Literature DB >> 17466004

Complex ABCC8 DNA variations in congenital hyperinsulinism: lessons from functional studies.

Morris Muzyamba1, Tabasum Farzaneh, Phillip Behe, Alison Thomas, Henrik B T Christesen, Klaus Brusgaard, Khalid Hussain, Andrew Tinker.   

Abstract

OBJECTIVE: Congenital hyperinsulinism (CHI) is a cause of persistent and severe hypoglycaemia in infancy. Mutations in the genes ABCC8 and KCNJ11 encoding SUR1 and Kir6.2, respectively, are the commonest cause of CHI. We investigated whether the possession of two DNA variants leading to coding changes in a single allele of ABCC8 can affect the potential mechanism of disease pathogenesis. DESIGN AND PATIENTS: We studied two patients with complex mutations in the ABCC8 gene with CHI and used in vitro studies to explore the potential disease mechanism and the contribution of the various mutant allelles.
RESULTS: The first case had diffuse disease and was homozygous for the mutations D1193V and R1436Q in SUR1. Channel complexes containing the D1193V mutant were delivered to the plasma membrane and were functional and those containing R1436Q were also present at the plasma membrane but were nonfunctional. Combining the two mutations (SUR1D1193V/R1436Q) led to intracellular retention of the channel complex. In a second family, the patient had histologically focal disease and was heterozygous for two mutations from his father (G228D and D1471N) and one from his mother (V1572I). SUR1 G228D and D1471N singly or in combination led to intracellular retention of the channel complex and loss of function. By contrast, V1572I is trafficked appropriately and is functional, consistent with a mechanism of reduction to hemizygosity of paternal ABCC8 in focal disease. V1572I is likely to be a benign DNA variant.
CONCLUSION: In one patient the combination of two coding variants led to intracellular retention of channel complex. In a second patient, functional studies allowed us to unravel the DNA variants likely to be causing the abrogation of ATP-sensitive K(+) channel function.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17466004     DOI: 10.1111/j.1365-2265.2007.02847.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  8 in total

1.  Regulation of the ATP-sensitive potassium channel subunit, Kir6.2, by a Ca2+-dependent protein kinase C.

Authors:  Qadeer Aziz; Alison M Thomas; Tapsi Khambra; Andrew Tinker
Journal:  J Biol Chem       Date:  2011-12-29       Impact factor: 5.157

Review 2.  Pulmonary Hypertension and ATP-Sensitive Potassium Channels.

Authors:  Conor McClenaghan; Kel Vin Woo; Colin G Nichols
Journal:  Hypertension       Date:  2019-05-28       Impact factor: 10.190

3.  Congenital hyperinsulinism: clinical and molecular characterisation of compound heterozygous ABCC8 mutation responsive to Diazoxide therapy.

Authors:  Ved Bhushan Arya; Qadeer Aziz; Azizun Nessa; Andrew Tinker; Khalid Hussain
Journal:  Int J Pediatr Endocrinol       Date:  2014-12-15

4.  Genotype and phenotype correlations in 417 children with congenital hyperinsulinism.

Authors:  K E Snider; S Becker; L Boyajian; S-L Shyng; C MacMullen; N Hughes; K Ganapathy; T Bhatti; C A Stanley; A Ganguly
Journal:  J Clin Endocrinol Metab       Date:  2012-12-28       Impact factor: 5.958

5.  In vitro insulin secretion by pancreatic tissue from infants with diazoxide-resistant congenital hyperinsulinism deviates from model predictions.

Authors:  Jean-Claude Henquin; Myriam Nenquin; Christine Sempoux; Yves Guiot; Christine Bellanné-Chantelot; Timo Otonkoski; Pascale de Lonlay; Claire Nihoul-Fékété; Jacques Rahier
Journal:  J Clin Invest       Date:  2011-09-26       Impact factor: 14.808

6.  Hyperinsulinaemic hypoglycaemia and diabetes mellitus due to dominant ABCC8/KCNJ11 mutations.

Authors:  R R Kapoor; S E Flanagan; C T James; J McKiernan; A M Thomas; S C Harmer; J P Shield; A Tinker; S Ellard; K Hussain
Journal:  Diabetologia       Date:  2011-06-15       Impact factor: 10.122

Review 7.  Pharmacological rescue of trafficking-impaired ATP-sensitive potassium channels.

Authors:  Gregory M Martin; Pei-Chun Chen; Prasanna Devaraneni; Show-Ling Shyng
Journal:  Front Physiol       Date:  2013-12-24       Impact factor: 4.566

8.  Loss-of-Function ABCC8 Mutations in Pulmonary Arterial Hypertension.

Authors:  Michael S Bohnen; Lijiang Ma; Na Zhu; Hongjian Qi; Conor McClenaghan; Claudia Gonzaga-Jauregui; Frederick E Dewey; John D Overton; Jeffrey G Reid; Alan R Shuldiner; Aris Baras; Kevin J Sampson; Marta Bleda; Charaka Hadinnapola; Matthias Haimel; Harm J Bogaard; Colin Church; Gerry Coghlan; Paul A Corris; Mélanie Eyries; J Simon R Gibbs; Barbara Girerd; Arjan C Houweling; Marc Humbert; Christophe Guignabert; David G Kiely; Allan Lawrie; Rob V MacKenzie Ross; Jennifer M Martin; David Montani; Andrew J Peacock; Joanna Pepke-Zaba; Florent Soubrier; Jay Suntharalingam; Mark Toshner; Carmen M Treacy; Richard C Trembath; Anton Vonk Noordegraaf; John Wharton; Martin R Wilkins; Stephen J Wort; Katherine Yates; Stefan Gräf; Nicholas W Morrell; Usha Krishnan; Erika B Rosenzweig; Yufeng Shen; Colin G Nichols; Robert S Kass; Wendy K Chung
Journal:  Circ Genom Precis Med       Date:  2018-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.